The first 1,000 days of life of a child, the period from conception to the end of the second year, is a critical stage for the development of respiratory and immune systems. Many factors occurred in this period may be associated to risk of asthma in childhood.
INTRODUCTION Study selection
The present review included systematic reviews with meta-analysis, or meta-analysis of observational and interventional studies on risk or protective factors for childhood asthma, emphasizing the period between the conception and two first years of age. Meta-analyses from databases, such as cohort studies, were also included. The main outcome was diagnosis of asthma, with or without verification of medical records, or the symptom of wheezing. Studies analyzing the main outcome in wide age range were included only if they included analyses in the childhood. Genetic and molecular research, as well as pharmacologic treatments, were excluded from this review.
This systematic review is in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement 8 , and it was registered in the International Prospective Register of Systematic Reviews (PROSPERO, CRD42017069852). Two researchers analyzed the results of the search independently to find potentially eligible studies. First, the studies were sorted according to title, then the abstracts were analyzed and only the potentially eligible studies were fully assessed. Based on the abstracts, full articles were acquired for full review and considered for analysis. Any disagreement between the researchers was resolved by consensus.
Data extraction and synthesis
Two researchers analyzed and extracted the data from the selected systematic reviews using a standardized form. The extracted information included: 1) number of studies included in each meta-analysis; 2) total number of subjects included in each study; 3) design of the studies included in each meta-analysis; 4) pooled odds ratio (OR) or relative risk (RR) and respective 95% confidence interval (CI); 5) measure of homogeneity among studies, such as I² statistic or Cochran's Q statistic. In the interpretation of heterogeneity, I 2 value of 0% indicates no heterogeneity, and larger values show increasing heterogeneity (25% -low, 50% -moderate and 75% -high) 9 . In this present review, the exposures were considered as "risk factor" or "protective factor" when the heterogeneity was null or low. and their main findings. According the AMSTAR tool, all included studies had a good methodological quality, except for one 42 (Table 2) . Four studies included in this review were meta-analyses from cohort studies, and did not perform a systematic review in the literature 28, 33, 43, 45 . For this reason, the methodological quality cannot be evaluated by the AMSTAR (Table 1 and Table 2 ).
Risk factors
Parental history of asthma is a well-known risk factor for childhood asthma. Maternal asthma can represent a 3-fold increased risk, while paternal asthma a 2.4 fold increase in the odds of asthma in childhood. During pregnancy, urogenital maternal infections and psychological stress increase the risk of asthma during childhood (OR = 1.39, CI 95% 1.18 -1.64, I 2 = 15%; OR = 1.56, CI 95% 1.36 -1.80, I 2 = 18%; respectively) 10 . Maternal smoking also increases the odds of asthma/ wheezing disorders in offspring (OR = 1.70, CI 95% 1.24 -2.35, I 2 = 0%) 27 . Due to moderate to high heterogeneity, the risk evidence between asthma in the offspring and maternal overweight and obesity was not consistent. However, each1-kg/m 2 increase in maternal body mass index is associated with a 2% to 3% increase in the odds of childhood asthma 13 . Antibiotic use during pregnancy significantly increase the risk of childhood asthma, especially in the second and third trimesters (OR = 1.14, CI 95% 1.01 -1.29; OR = 1.33, CI 95% 1.11 -1.60, respectively; I 2 = 0% for both) 23 as well as paracetamol use (second/third trimesters, OR = 1.49, CI 95% 1.37 -1.63, I 2 = 0%) 26 . The causal association between asthma and antibiotics exposure after birth until two years of life as well as paracetamol exposure remains inconclusive due to the high heterogeneity between studies and potential biases.
Caesarean section can increase the risk of asthma in the offspring (OR range 1.16 to 1.20, I 2 ≈ 25%). However,
Quality assessment
Two independent researchers analyzed the methodological quality of the eligible systematic reviews using the AMSTAR tool (A Measurement Tool to Assess Systematic Reviews). The AMSTAR tool consists of 11 items and each item has the options yes; no; cannot answer; or not applicable. Each answer "yes" receives one point. In the present review, studies scoring 8 or more points were considered as having good quality.
RESULTS
A total of 540 articles were identified in the databases. Hand searching identified nine additional titles. Among these articles, 74 were selected by the title and had their abstracts reviewed. Based on the abstracts, 69 studies were selected for a full review. Thirty-six studies met the eligibility criteria, whereas 33 studies were excluded ( Figure 1 ). These exclusions were due to the following reasons: seventeen studies were not limited to analyze exposures occurred in the early life; six studies were systematic reviews without meta-analysis; four studies were narrative reviews; three studies were protocols of systematic reviews; one study had allergic sensitization as outcome; one study had only pulmonary function as outcome; and one study had hospitalizations for asthma as outcome.
The remaining studies examined the follow exposures: family history 10 , maternal infections 11 , maternal stress 12 , maternal weight and gestational weight gain 13 , maternal nutrition 14 , folate supplementation 15, 16 , probiotics use 17, 18 , fish and oil fish intake 19 , antibiotic use [20] [21] [22] [23] , paracetamol use [24] [25] [26] , parental and household smoking 27, 28 , caesarean section 29, 30 , prematurity [31] [32] [33] , birth weight [33] [34] [35] [36] , hyperbilirrubinemia 37 , breastfeeding 38, 39 , Bacillus Calmette-Guérin (BCG) vaccination 40, 41 , pets ownership 42, 43 , endotoxins 44 , and mold/dampness 45 . In Table 1 displays general characteristics of the studies Vitamin D intake: I2 = 59%; p = 0.06 Vitamin E intake: I2 = 0%; p = 0.89
Zinc intake: I2 = 0%; p = 0.60
Fish and fish oil intake Newborn's fish exposure: I2 = 11.5%; p = 0.323 Fatty acids in maternal expressed breast milk: I2 = 0%; p = 0.359 Overall: I 2 = 82.9%; p = 0.001 Case-control: I 2 = 90%; p = 0.001 Cohort: I 2 = 42.3%; p = 0.109
Strict criteria: I 2 = 46.7%; p = 0.095
Stratification by trimesters of pregnancy:
Overall: I 2 = 0%; p = 0.699
First trimester: I 2 = 0%; p = 1 First trimester: I2 = 64.2%; p = 0.025 Second/third trimester: I2 = 0%; 0.833
Third trimester: I2 = 0%; p = 0.796 -First 2 years of life: Any versus no paracetamol intake unadjusted: I2 = 0%; p = 0.884
Any versus no paracetamol intake adjusted*: I2 = 0%; p = 0.795 Frequency of paracetamol intake unadjusted: : I2 = 0%; p = 0.570 Frequency of paracetamol intake adjusted*: I2 = 0%; p = 0. -Preschool wheezing: Q = 28; p = 0.424; I² = 3% -School-age asthma: Q = 29; p = 0.034; I² = 42% -Low birth weight: Preschool wheezing: I2 = 15%; p = 0.244 School-age asthma: I2 = 0%; p = 0.787 -Asthma: Cat versus no pets: I2 = 9%; p = 0.36 Dog versus no pets: I2 = 0%; p = 0.89 Cat /dog versus no pets: I2 = 33%; p = 0.18 Bird versus no pets: I2 = 21%; p = 0.25 Rodent versus no pets: I2 = 0%; p = 0.84 -Allergic asthma: Cat versus no pets: I2 = 21%; p = 0.26 Dog versus no pets: I2 = 0%; p = 0.95 Cat /dog versus no pets: I2 = 59%; p = 0.06
Continuation -
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N. of studies N. of subjects Study design Period of exposure OR or RR (95% CI) for meta-analysis Heterogeneity
Continuation - Table 1 : Characteristics of included studies and main findings of the meta-analyses of risk and protective factors for childhood asthma In this table, the number of studies and participants included in each meta-analysis is specifically related to asthma or wheezing cases, or outcomes during childhood or exposure during pregnancy and first two years. BCG, Bacillus Calmette-Guérin; BMI, body mass index; CI, confidence intervals; OR, odds ratio; PB, population based; PBC, population-based cohort; RR, relative risk. Was the scientific quality of the included studies used appropriately in formulating conclusions? 9. Were the methods used to combine the findings of studies appropriate? 10. Was the likelihood of publication bias assessed? 11. Was the conflict of interest included? Figure 2 : Protective and risk factors for childhood asthma and wheezing disorders in the first 1,000 days due to the moderate to high heterogeneity between the studies, differences between elective and emergency caesarean sections are not consistent 29, 30 . As for birth weight, both low (<2.5kg) and high (>4.0kg) birth weight are associated with a slight increase in asthma and wheezing disorders in preschool and school age [34] [35] [36] . Neonatal hyperbilirrubinemia increases more markedly the risk of childhood asthma (OR = 4.26, CI 95% 4.04 -4.50, I 2 = 0%) 37 .
Protective factors
Intake of fish oil, zinc and vitamin E during pregnancy decreases the risk of childhood wheezing 14 . However, this beneficial effect could not be verified when the outcome analyzed was childhood asthma. After birth, ever breastfeeding, especially in middle/low income countries, reduces the risk of childhood asthma when compared to never breastfeeding (OR = 0.78, CI 95% 0.70 -0.88, I 2 = 0%) 39 . Newborn's fish intake is also a protective factor for asthma (OR = 0.7, CI 95% 0.61 -0.94, I 2 = 11.5%) 19 , as well as BCG vaccination (OR range 0.86 to 0.94, I 2 range 0% to 26%) 40, 41 . However, the protective factor BCG vaccination is relatively short-lived, being lost in adolescence. Protective and risk factors for childhood asthma and wheezing disorders in the first 1,000 days are summarized in Figure 2 .
The icons used in the elaboration of this figure were extracted from the electronic address: http://www.sarihusada. co.id/en/About-Us/First-1000-Days-of-Life/Detail-For-the-First-1000-Days-of-Life.
DISCUSSION
Summary of evidence
The results from meta-analyses provide evidence that parental history of asthma, maternal weight gain during pregnancy, maternal urogenital infections, maternal psychological stress, maternal smoking, caesarean section, preterm birth, birth weight, and neonatal hyperbilirrubinemia are risk factors for childhood asthma/wheeze. In the other hand, intake of fish oil, zinc and vitamin E during pregnancy appear as protective factors as well as breastfeeding, fish intake in the first two years, and BCG vaccination, although discreetly in the case of the last one. There is insufficient evidence to recommend any dietary pattern or folic acid supplementation and probiotic administration to prevent asthma. Also, there is no evidence that pets' ownership increases or decreases the risk of childhood asthma. The lack of consistence in the findings (moderate to high heterogeneity), coupled with the possible biases of the studies, further hinder conclusions about the role of endotoxins, mold, dampness, antibiotics and paracetamol exposures in the development of asthma and wheezing disorders.
Are there any explanations to these associations?
Several possible biological causal pathways could explain the increased risk of asthma. However, some potential mechanisms are not fully understood. Humans are born Th2skewed, and gradually develop a Th1/Th2 balance. However, in asthma and other allergic diseases, a Th2-polarized immune deviation has been observed 46 . The imbalance in circulating Th1-and Th2-associated chemokines may precede the onset of wheeze from birth, implicating that these chemokines may sometimes be primarily involved in the pathogenesis of allergic diseases and not only secondarily to a general immune deviation after disease onset 47 .
Fetal exposure to inflammatory cytokines has been linked to chronic lung diseases 48 . Since fetal lung and skin are in constant contact with amniotic fluid, exogenous toxins or mediators of inflammation released through the placenta may lead to fetal exposure. Increased inflammation within the placenta may alter fetal cytokine levels thereby affecting the immune system development and resulting in differential response to allergens later in life. This mechanism can explain the association between asthma and maternal infections, as well as the association between asthma and maternal weight gain, since maternal obesity increases concentrations of lipids and pro-inflammatory mediators like TNFα, IL-1, and IL-6 in the placenta 49 . In another way, nutritional components such as long-chain n-3 polyunsaturated fatty acids from fish and fish oil intake have the ability to inhibit the production of prostaglandin E2, suppress Th2 cell's response to allergens and consequently modulate the intensity and duration of inflammatory responses. For this reason, it has been hypothesized that the increased intake of long-chain n-3 polyunsaturated fatty acids can reduce the risk of atopic diseases such as asthma 50 .
Maternal smoking, mainly during pregnancy, also has significant immunologic effects that could contribute to increased risk of respiratory infections and asthma. Maternal smoking during pregnancy is associated with higher cord blood immunoglobulin E levels, as well as lowers Th1 responses to polyclonal stimulation. Furthermore, it is associated with stronger neonatal allergen-specific responses, and can affect Tolllike receptor innate defense pathways, which could both explain an increased susceptibility to infection and have implications for subsequent allergen-specific immune development 51 . The release of hypothalamic corticotropin hormone, which can be induced by maternal psychological stress, leads to systemic secretion of glucocorticoids and catecholamines 52 . In this way, it can also influence immune responses in the offspring, because both glucocorticoids and catecholamines mediate a Th2 shift by up-regulating Th2-cytokine production and suppressing antigen-presenting cells and Th1 cells 53 .
Oxidative stress plays a critical role in the pathogenesis of asthma 54 . Pro-oxidant and antioxidant imbalance can cause dysfunction in cell signaling and arachidonic acid metabolism and increase airway and systemic inflammation 55 . By acting as an antioxidant, vitamin E may inhibit secretion of IL-4 by T cells 56 , and this is possibly one reason for the reduced risk of asthma in children. In another way, bilirubin, at higher levels, might act as a strong pro-oxidant that might induce airway inflammation and development of asthma later in life. Bilirubin also can strongly inhibit the Th1 cell response and lead to a delay in the Th2 to Th1 switch 57 . Besides this, unconjugated bile acids inhibit the growth of intestinal anaerobic bacteria, which change the gut microbiota composition, and the prevention of Th1 response, influencing the development of allergic diseases 58 . Intestinal bacterial flora is important to the children's immune system development. The delivery mode can affect this development, since in caesarean section, children are not exposure to the vaginal flora that cause alterations in intestinal bacterial flora, such as in the case of bifidobacterium species 59 . Human breast milk also plays an important role in the establishment of favorable gut colonization. In addition to having immunomodulating properties, transforming growth factor β is a cytokine present in the human milk that is involved in the maintenance of intestinal homeostasis and inflammation regulation 60 . These mechanisms can explain the protective effect of breastfeeding in asthma and other allergic diseases.
Other potential explanations for the increase of risk of asthma are anatomical and immunological immaturity. Preterm birth might increase the risk of asthma because the lungs of a preterm infant are not fully developed anatomically or immunologically, and this immaturity might make the child more susceptible to later exposures capable of causing asthma 31 . Similarly, children with low birth weight may have disturbances in lung development, which would cause a greater sensitivity to external environmental stimuli and result in an increased risk of asthma 35 . Also related to lung development, zinc deficiency has been associated with impaired fetal lung growth in rats 61 . Based on this finding, we can postulate that zinc supplementation is beneficial for lung growth, which explain the association between zinc supplementation during pregnancy and decrease in the risk of childhood asthma.
Limitations
In this review, the meta-analyses that were not systematic reviews were included because they brought data from big cohort studies, with a significant number of participants. However, the AMSTAR tool cannot evaluate the methodological quality of these studies. Many meta-analyses showed to have moderate to high heterogeneity, reveling lack of consistence in the findings. The lack of homogeneity, coupled with the possible biases, hinder strong evidences about some exposures in early life. In addition, studies with other potential risk factors, such as respiratory syncytial virus infection, were not included in this review because the meta-analyses published so far do not restrict exposure to the first 1,000 days of life.
Clinical implications
Current findings suggest that several modifiable behaviors or exposures can be associated with asthma and wheezing in childhood. Although the pooled odds ratios in many meta-analyses have found associations, measures of heterogeneity suggest a lack of consistent in many findings. Awareness of these modifiable behaviors and exposures, as well as the knowledge about the close links between early-life lung events, immune maturation and childhood respiratory diseases can improve early prevention strategies with a view to ensuring a beneficial impact on both short-and long-term respiratory health 62 .
CONCLUSION
There are still many aspects that need to be considered and further explored. Knowledge about the risk factors present in the first 1,000 days of life of children can support approaches and interventions capable of modifying the risk of asthma and/or changing the course of the disease in childhood. Understanding these potentially modifiable factors is of great interest for the planning of public health policies, being as relevant as new clinical treatments for asthma 63 .
